The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

糖尿病，这一日益普遍的慢性疾病，不仅影响着患者的代谢健康，还可能带来一系列严重的并发症，其中糖尿病视网膜病变（Diabetic Retinopathy， 简称DR）尤为令人担忧。作为糖尿病最常见的眼部并发症之一，DR是导致视力丧失的四大原因之一，严重影响着患者的生活质量和健康。让我们一起深入探讨糖尿病视网膜病变的成因、症状、诊断、治疗及预防措施，帮助糖尿病患者更好地认识并应对这一威胁。 一、糖尿病 ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

ARCATUS or ARVN001, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries is formally known as XIPERE in the United States and was developed by Clearside Biomedical.

Diabetic patients frequently suffer from retinopathy, nephropathy, neuropathy and accelerated atherosclerosis. The loss of endothelial function precedes these vascular alterations. Here we report ...

Centers for Disease Control and Prevention. Diabetes and women. National Institute of Health: National Eye Institute. Diabetic retinopathy. Johns Hopkins Medicine. Dehydration and heat stroke.

Diabetic macular edema (DME) is the leading cause of visual loss secondary to diabetic retinopathy(1, 2). In patients with DME, a long-acting dexamethasone release system (0.70 mg; Ozurdex) reduces ...